Ara
Toplam kayıt 8, listelenen: 1-8
Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review
(Springer, 2021)
Objective To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a ...
Prostate cancer multifocality, the index lesion, and the microenvironment
(Lippincott Williams & Wilkins, 2018)
Purpose of reviewMost of focal therapies has addressed index lesion as the targeted tumour focus to treat localized prostate cancer (PCa), a multifocal disease. The interaction between tumour foci and host cells creates a ...
Available evidence on HIFU for focal treatment of prostate cancer: A systematic review
(NLM (Medline), 2022)
PURPOSE: Prostate cancer (PCa) is the second most common oncologic disease among men. Radical treatment with curative intent provides good oncological results for PCa survivors, although definitive therapy is associated ...
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies
(Nature Publishing Group, 2019)
Despite improvements in early detection and advances in treatment, patients with prostate cancer continue to die from their disease. Minimal residual disease after primary definitive treatment can lead to relapse and distant ...
Imaging and technologies for prostate cancer. Where are we now-where do we go?
(Springer, 2021)
We have been witnessing rapid advances in the diagnosis and treatment of prostate cancer. While some approaches have matured, others are still in their infancy. We have learned that Active Surveillance is safe in patients ...
A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply.
(Wolters Kluwer Health, 2023)
To the Editor: We appreciate this opportunity toaddress the concerns in the comment by Jin et al on ourarticle,1evaluating the adverse events and quality of lifeafter irreversible electroporation (IRE) for the ablationof ...
Focal therapy for prostate cancer: Evolutionary parallels to breast cancer treatment. Letter.
(Wolters Kluwer Health, 2023)
To the Editor:We read with great interest the recentmanuscript by Labbate et al reviewing the develop-ment of focal therapy in breast and prostate cancer(PCa).1Breast focal therapy (bFT) represents a suc-cessful model for ...
A survey of artificial intelligence/machine learning-based trends for prostate cancer analysis
(2024)
Different types of cancer are more commonly encountered recently. This may be attributed to a variety of reasons, including heredity, changes in the living conditions (food, drinks, pollution, etc.), advancement in technology ...